Key facts
- Notable investors include Huaxi Securities Investment.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Gelai
- ·The full record, as it builds
Funding rounds
No funding rounds for Gelai are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Gelai
Manufacturer of preparative liquid chromatography systems, peptide synthesiser lysis systems, and solvent circulation equipment intended to enhance pharmaceutical production and purification processes. The company offers advanced engineering capabilities, customized sample preparation technologies, and integrated high-end equipment, enabling pharmaceutical manufacturers and research institutions to improve product quality, reduce operational costs, and achieve sustainable development.
- Sector
- Healthcare
- HQ
- Chengdu, China
- Founded
- 2018
- Website
- cdgelai.com/
- Ownership
- Privately Held (backing)
Gelai doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Gelai shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Gelai in its N-PORT filings yet. We sweep new filings monthly.